These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36865686)

  • 1. The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease.
    Li M; Liu D; Jing F; Liu R; Yi Q
    Front Pediatr; 2023; 11():1111788. PubMed ID: 36865686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
    Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.
    Yang M; Weng H; Pei Q; Jing F; Yi Q
    Mediators Inflamm; 2021; 2021():7029514. PubMed ID: 33505217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explorative case control study on the associations of serum vitamin D3, folic acid and vitamin B12 levels on Kawasaki disease and coronary artery lesions.
    Chen Y; Liu X; Li B; Li J; Meng L; Ye C; Han L; Li H; Deng LL; Su Z; Zhang X
    Front Nutr; 2024; 11():1402316. PubMed ID: 38919394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
    Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
    Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
    Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
    Xu YM; Chu YQ; Wang H
    Front Pediatr; 2021; 9():704929. PubMed ID: 34660478
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
    Feng S; Su Y; Luo L; Jing F; Yi Q
    Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
    Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease.
    Wu R; Jiang W; Sun Y; Wu L; Di Y; Wang J; Zhong S; Wang W
    J Clin Rheumatol; 2023 Apr; 29(3):126-131. PubMed ID: 36730421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of VEGF in the Pathogenesis of Kawasaki Disease.
    Chen CY; Huang SH; Chien KJ; Lai TJ; Chang WH; Hsieh KS; Weng KP
    Children (Basel); 2022 Sep; 9(9):. PubMed ID: 36138652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy.
    Senzaki H; Kobayashi T; Nagasaka H; Nakano H; Kyo S; Yokote Y; Sasakid N
    Pediatr Res; 2003 Jun; 53(6):983-8. PubMed ID: 12621103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
    Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
    Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease.
    Ching LL; Nerurkar VR; Lim E; Shohet RV; Melish ME; Bratincsak A
    Front Pediatr; 2020; 8():295. PubMed ID: 32670996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.